< Back to previous page
Researcher
Johan Neyts
- Disciplines:Microbiology, Systems biology, Laboratory medicine
Affiliations
- Faculty of Medicine (Faculty)
Member
From1 Oct 2000 → 30 Sep 2002 - Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Oct 1999 → Today
Infrastructure
1 - 1 of 1
Projects
1 - 10 of 82
- Developing broad-spectrum antiviral drugs for pandemic preparednessFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- New AntiVirals for Infections with Pandemic PotentialFrom1 Jan 2024 → TodayFunding: HORIZON.2.1 - Health
- European Viral Outbreak Response AllianceFrom1 Jan 2024 → TodayFunding: HORIZON.1.3 - Research Infrastructures
- Classic and new strategies to fight alphavirusesFrom18 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- The Impact of SARS-CoV-2 Vaccine R&D decisions on the downstream Covid-19 Immunization System - Improving Strategic and Operational Preparedness for Future Virus Crisis OutbreakFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Towards strategies for the treatment and prevention of henipavirus infections.From21 Nov 2022 → TodayFunding: FWO Strategic Basic Research Grant
- HTS to discover direct-acting small molecule inhibitors of henipavirusesFrom16 Nov 2022 → TodayFunding: Foreign private sponsor - undefined
- Prepared for SARS-CoV-3: advancing our understanding of SARS coronavirus antigenic and pathogenic evolutionFrom1 Jan 2022 → TodayFunding: FWO EOS
- VirusBank platform (state-of-the-art research platform for increased preparedness against viral epidemics and pandemics)From1 Jan 2022 → TodayFunding: Ministery of Economical Affairs
Publications
11 - 20 of 621
- Lack of antiviral activity of probenecid in vitro and in Syrian golden hamsters(2024)
Authors: Dirk Jochmans, Johan Neyts
Pages: 172 - 178 - Multiplexed multicolor antiviral assay amenable for high-throughput research(2024)
Authors: Li-Hsin Li, Yun-An Huang, Madina Rasulova, Hendrik Jan Thibaut, Sebastiaan ter Horst, Joana Duarte Da Rocha Pereira, Suzanne Kaptein, Pieter Leyssen, Johan Neyts, Kai Dallmeier
- Comparing the Infectivity of Recent SARS-CoV-2 Omicron Sub-Variants in Syrian Hamsters(2024)
Authors: Rana Abdelnabi, Piet Maes, Birgit Weynand, Johan Neyts
- Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors.(2024)
Authors: Johan Neyts
Pages: 87 - 109 - A Robust Phenotypic High-Throughput Antiviral Assay for the Discovery of Rabies Virus Inhibitors(2023)
Authors: Johan Neyts, Dirk Jochmans
- A new alkaloid from Pancratium maritimum - Structure elucidation using computer-assisted structure elucidation (CASE) and evaluation of cytotoxicity and anti-SARS-CoV-2 activity(2023)
Authors: Steven De Jonghe, Johan Neyts, Christophe Pannecouque
Pages: 1 - 7 - Toward antivirals against hepatitis E: In the steps of hepatitis C.(2023)
Authors: Johan Neyts
Pages: 1695 - 1697 - Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.(2023)
Authors: Steven De Jonghe, Kim Donckers, Dirk Jochmans, Johan Neyts
Pages: eabo7201 - Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411(2023)
Authors: Dirk Jochmans, Johan Neyts
- Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters(2023)
Authors: Rana Abdelnabi, Winnie Kerstens, Hendrik Jan Thibaut, Lotte Coelmont, Birgit Weynand, Johan Neyts, Kai Dallmeier
Patents
1 - 10 of 10
- Corona virus binders (Inventor)
- Lassavirus vaccines (Inventor)
- Chimeric filovirus vaccines (Inventor)
- Chimeric zika-japanese encephalitis virus (Inventor)
- Chimeric yellow fever zika virus strain (Inventor)
- Viral replication inhibitors (Inventor)
- Treatment and prevention of dengue disease (Inventor)
- Coronavirus vaccines (Inventor)
- Design synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity (Inventor)
- Treatment and prevention of dengue disease (Inventor)